Answer
As an adjunct professor in Cellular and Molecular Pharmacology at UCSF, Jennifer Doudna brings her expertise to the field that focuses on understanding the molecular mechanisms and cellular processes underlying drug responses and pharmacological interventions, including the groundbreaking CRISPR-Cas9 gene editing technology she co-developed, offering valuable insights for future therapeutic advancements.